View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
November 4, 2019

Colson Associates divests Medical Companies to Marmon

Marmon Holdings, a Berkshire Hathaway unit, has acquired a 60% interest in the Colson Medical Companies from Colson Associates.

Marmon Holdings, a Berkshire Hathaway unit, has acquired a 60% interest in the Colson Medical Companies from Colson Associates.

Free Report
img

What’s missing from your IPO industry assessment?

IPO activity all but stopped in 2020, as the investment community grew wary of the effects of COVID-19 on economies. No matter how deserving a business was of flotation, momentum was halted by concerns of when a ‘new normal’ of working patterns and trade would set in. Recently, sentiment has changed. Flotations picked up again during the second half of 2021, and now in 2022 the mood is decidedly optimistic. Business leaders have their eyes on fast rebounding economies, buoyant market indices and the opportunity once again to take their businesses public. As a result, global IPOs are expected to hit back this year. With GlobalData’s new whitepaper, ‘IPOs in Consumer and Retail: 5 must-include elements for your prospectus industry report’, you can explore exactly what is needed in the essential literature. GlobalData’s focus lies in the critical areas to get right:
  • Macroeconomic and demographic environment
  • Consumer context
  • Industry environment
  • Competitive environment
  • Route to market
Interested to learn more about what to include in your IPO Industry Assessment report? Download our free whitepaper.
by GlobalData
Enter your details here to receive your free Report.

Marmon intends to buy the remaining 40% over the next five years. Financial details of the transaction are yet to be divulged by either company.

Chicago businessman Robert Pritzker founded Colson Associates.

Pritzker co-founded Marmon in 1953, later establishing Colson Associates after retiring as the former company’s CEO in 2002. Pritzker then acquired Colson Medical Companies and added businesses from Marmon.

Marmon chairman and CEO Angelo Pantaleo said: “We are excited to welcome the Colson Medical Companies back home to Marmon. Their innovative, proprietary products and processes and outstanding reputation make them an ideal fit for Marmon and provide our organisation with another strong growth platform.”

Colson Medical develops, manufactures and distributes speciality medical devices worldwide. Its portfolio consists of engineered plates and screws, along with related precision tools used in orthopaedic surgery.

The products are available through Acumed, MicroAire, Precision Edge, Apex, OsteoMed and Skeletal Kinetics businesses.

Marmon acquired all these businesses, except Apex and Skeletal Kinetics, between 1979 and 1999.

Together, the companies have more than 1,300 employees across the US, UK, Spain, China and Germany.

Berkshire Hathaway chairman and CEO Warren Buffett said: “The speciality medical device market is an attractive growth opportunity and the Colson businesses are highly regarded. Berkshire and Marmon will provide a home where these businesses can continue to flourish.”

Colson Medical Companies will operate as a sector within Marmon, led by Colson’s current president Chris Smith.

Marmon is an industrial organisation with ten different business sectors and more than 125 autonomous manufacturing and service businesses.

Last year, the company recorded revenues of more than $8.1bn.

Related Companies

Free Report
img

What’s missing from your IPO industry assessment?

IPO activity all but stopped in 2020, as the investment community grew wary of the effects of COVID-19 on economies. No matter how deserving a business was of flotation, momentum was halted by concerns of when a ‘new normal’ of working patterns and trade would set in. Recently, sentiment has changed. Flotations picked up again during the second half of 2021, and now in 2022 the mood is decidedly optimistic. Business leaders have their eyes on fast rebounding economies, buoyant market indices and the opportunity once again to take their businesses public. As a result, global IPOs are expected to hit back this year. With GlobalData’s new whitepaper, ‘IPOs in Consumer and Retail: 5 must-include elements for your prospectus industry report’, you can explore exactly what is needed in the essential literature. GlobalData’s focus lies in the critical areas to get right:
  • Macroeconomic and demographic environment
  • Consumer context
  • Industry environment
  • Competitive environment
  • Route to market
Interested to learn more about what to include in your IPO Industry Assessment report? Download our free whitepaper.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network